Navigation Links
AcCELLerated Biologics Launches Distribution Partnership with CEP-Topical Gear T:25 Technology
Date:9/27/2017

AcCELLerated Biologics, a leading independent medical distribution and consulting firm that helps physicians worldwide provide their patients with advanced autologous products and hardware such as platelet rich plasma (PRP), bone marrow aspirate (BMA), Marrow Cellution (Stem Cell needle), MiMedx (AmnioFix & OrthoFlo) and VisionScope Imaging, announced today that it has entered into a new distribution partnership with sports medicine company CEP-Topical Gear T:25 Technology.

“This dynamic partnership with CEP-Topical Gear T:25 Technology establishes AcCELLerated Biologics as the first independent medical distribution and consulting firm to offer physicians a post-injury treatment rehabilitation protocol and product,” commented Steve Whyte, AcCELLerated Biologics’ founder and CEO. “We are excited about the opportunity to work with CEP-Topical Gear T:25 Technologies’ leadership team led by Bill Bue. Bill and I recognize that the timing is ideal for both organizations to work together. Our goal is to combine our best abilities in this market to serve physicians, patients and communities across the country. A win for all!”

“Topical Gear is excited to partner with AcCELLerated Biologics, a company that has set high expectation internally and mirrors our vision of what the biologic market needs today,” commented Bill Bue, Topical Gear’s founder and CEO.
“Offering post-injury products with CEP-Topical Gear T:25 technology provides the physician with an option they did not have a week ago. Now the physician can be comfortable having a post rehabilitation protocol that will allow patients and athletes faster recovery and return to work or sport.”

Topical Gear was formed in 2010 by a team of orthopedic sports medicine professionals to create performance wearables with groundbreaking CEP-Topical Gear T:25 Technology, which trains key muscles and enhances neuromuscular communication necessary to help a patient or athlete with faster recovery following treatment.

A strategic relationship between CEP and Topical Gear was formed in 2016 which incorporates T:25 technology into the manufacturing of CEP outstanding sport compression products. CEP has dominated the marathon and tri athlete markets for years, and is excited to expand their presence into Regenerative and Sports Medicine.

For additional information, including product and order inquiries, visit our online store:
https://accellerated-biologics.myshopify.com, email info(at)accelleratedbiologics(dot)com, or phone toll-free (800) 367-0844.

About AcCELLerated Biologics
Uniquely positioned within the field of biologics, AcCELLerated Biologics is a leading independent medical distribution company focused on consulting and providing the physician, their staff and community with quality information and products related to platelet rich plasma, stem cells, bone marrow concentrate, and other advanced autologous products that support the use of biologics. AcCELLerated Biologics is a reliable and trustworthy partner for physicians that want to introduce or use biologics in their practice. Learn more at https://www.accelleratedbiologics.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14739393.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Veterinary Growth Partners Selects MediVet Biologics as Preferred Vendor for Veterinary Biologics
2. 3Bar Biologics Secures $2M To Help Farmers Increase Crop Yields with Naturally Occurring Microbes
3. Merck uses Genedata Biologics to Scale-Up Bispecific Antibody Discovery Programs
4. Heritage Biologics Earns URAC Accreditation in Specialty Pharmacy
5. MediVet Biologics Launches Innovative Immunotherapy Trial for Canine Cancer
6. Catalent Biologics Announces Collaboration with Therachon, Switzerland, to Advance Clinical Development of Innovative Protein Therapy for Achondroplasia
7. Applied BioMath, LLC announces collaboration with Northern Biologics for semi-mechanistic PK/PD modeling in Oncology
8. Pall ForteBio Launches the Octet RED96e System for More Versatile Biologics Characterization
9. Pre-Filled Syringes West Coast Reports New Updates in Regulation, Biologics, Device Design and Manufacturing
10. WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC
11. Research Reports Initiation on Biotech Stocks -- Sangamo, Eyegate Pharma, Synthetic Biologics, and Regulus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... and VIENNA, Austria (PRWEB) , ... September 10, 2018 , ... ... supplier of Semantic Graph Database technology, AllegroGraph , for Knowledge Graphs, and ... provider of Semantic AI solutions, today announced a partnership to develop the Noam ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... 25th-28th is a meeting of “The industry’s preeminent event on novel drug targets.” ... scientists powerful tools to study these emerging targets in a quest to find ...
(Date:8/31/2018)... ... August 29, 2018 , ... A recent ... of Southampton and the Institute of Industrial Science, the University of Tokyo, demonstrated ... accelerate the exploration and study of hard to reach deep sea ecosystems, like ...
(Date:8/29/2018)... ... August 28, 2018 , ... ... the results of a safety study performed on an allogeneic (donor derived) stem ... Regenerative Medicine Association (NAVRMA) conference in September. He is also the organizer ...
Breaking Biology Technology:
(Date:9/15/2018)... , ... September 14, 2018 , ... The first ever ... of clearance of green, blue, and purple tattoo inks - often the colors most ... Medicine (LSM), the official journal of the American Society for Laser Medicine and Surgery, ...
(Date:9/12/2018)... ... September 12, 2018 , ... ... education, is pleased to support the professional development of academic librarians by sponsoring ... , The entrants were asked to submit successful strategies to increase collaboration among ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... ... Amedica Corporation (NASDAQ: AMDA) to purchase its commercial spine business, which includes its ... directly related to the spine that result from it. The deal will make ...
Breaking Biology News(10 mins):